Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP · NASDAQ Capital Market
+$0.70 today
Vol 0.37M · Avg 0.47M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-66.70%
Period High
$61.57
Period Low
$10.65
Latest
$11.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$283.43M
Forte Biosciences, Inc.
NASDAQ:FBRX
$243.83M
Fate Therapeutics, Inc.
NASDAQ:FATE
$240.11M
Eledon Pharmaceuticals, Inc.
NASDAQ:ELDN
$214.02M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$166.70M
Innate Pharma S.A.
NASDAQ:IPHA
$165.27M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$55.20M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest TNXP filing?
The latest filing shown is 4 dated Jun 9, 2026.
How many recent filings does TNXP have?
Intrinsic Alpha currently shows 20 recent filings for TNXP.
Explore More
Continue the stock analysis
Jump to another research area for this company.